Andrew Carragher

Andrew Carragher


Andrew is a Founder and Managing Director of DW Healthcare Partners, a private equity fund that invests exclusively in healthcare companies. DW Healthcare Partners has invested in 16 healthcare companies to date and currently manages over $500 million in institutional capital across three Funds. He has and currently sits on the Board of Directors of Genesis Technology Partners, Verathon, Tandem Labs, Reliant Renal Care, Pentec Health, Career Step, St. Andrews Management Services, Reliant Rehabilitation and Aerosol Science Labs. Andrew’s investment experience includes clinical research organizations, dialysis clinics, specialty infusion, clinical labs and medical devices.

Prior to co-founding DWHP, Andrew was Vice President of Business Development at Ventro Corporation and Director of Corporate Development/Mergers and Acquisitions at Total Renal Care (now Davita), an operator of 500 dialysis clinics. Andrew also worked for Bain & Company early in his career.

Andrew was raised in Toronto, Canada. He received his Bachelors degree in Business Administration from the University of Western Ontario and his MBA from Harvard Business School.

Andrew was recognized in 2006 as one of Utah’s Top 40 Under 40 and was a previous member of Utah’s YPO chapter.